Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) "CLINICS"


Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Diagnosis of heart failure according to Framingham criteria
- Informed consent
- Age 18 years or above

Exclusion Criteria

- Patients with a history of an untreated malignancy (except local skin cancers)
- Ischemic stroke (determined using the Questionnaire for Verifying Stroke-Free Status (QVSFS)
- Patients on renal dialysis or with end-stage hepatic dysfunction
- Acute infection/inflammation (Temperature > 101.5 F, and/or WBC> 15, 000)
- Inability to obtain informed consent from patient or next of kin
- Anticoagulant use (warfarin or heparin)